Myoclonus-dystonia (DYT11, DYT-SGCE) - a channelopathy?

Neurol Neurochir Pol. 2020;54(1):3-5. doi: 10.5603/PJNNS.a2020.0013.

Abstract

Introduction: Kaczyńska et al. reported a family with myoclonus-dystonia (M-D) caused by a truncating SGCE mutation, in which two members had epilepsy. Further, patients had mild psychiatric and developmental deficits.

Clinical reflections: Characteristic motor features of M-D include myoclonus, dystonia and tremor. A wide range of additional disease manifestations are known. A few patients with M-D have seizures.

Clinical implications: Altered neuronal excitability has been found in the pathogenesis of M-D. This may explain the partial effectiveness of antiepileptics and a lower seizure threshold, and could encourage trials of other membrane stabilisers. Careful clinical observations of seemingly well-known diseases remain important.

Keywords: DYT11; SGCE; myoclonus-dystonia; phenotype.

MeSH terms

  • Channelopathies*
  • Dystonic Disorders*
  • Humans
  • Sarcoglycans

Substances

  • SGCE protein, human
  • Sarcoglycans

Supplementary concepts

  • Myoclonic dystonia